Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1001900

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of automated medicine cabinets in reducing the number of deaths linked to medication errors in the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	188103
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>I refer the hon. Member to the answer I gave on 9 October 2018 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2018-09-12/174059/" target="_blank">174059</a>.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/11/2018 11:39:34 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4131 label Biography information for Jim Shannon

1001902

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential cost savings to the NHS of making automated medicines cabinets mandatory in every NHS trust.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	188105
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>No such cost analysis has been performed.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/11/2018 11:47:30 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4131 label Biography information for Jim Shannon

1001903

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the number of medication errors that result in serious harm to patients; and if he will make a statement.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	188106
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>The Department works with NHS Improvement, NHS England, the Medicines and Healthcare products Regulatory Agency (MHRA), Public Health England, and the Medication Safety Officer Network to improve the safety of medicine use across the National Health Service in England.</p><p> </p><p>The Medication Safety Programme, covering the NHS in England, has been established to take up the World Health Organization’s (WHO) global challenge to reduce the incidence of severe and avoidable harm in relation to medication globally by 50% over five years. Progress to date includes the publication of the Short Life Working Group into Reducing Medication Harm and the publication of an evidence-based review on the Prevalence and Economic Burden of Medication Errors in the NHS in England, which has helped the programme to understand the scale of the issue and identify key areas for improvement.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/11/2018 11:43:41 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4131 label Biography information for Jim Shannon

1001904

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of how much medication errors have cost the NHS in each year for which information is available; and if he will make a statement.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	188107
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>The Department commissioned a study by the Policy Research Unit in Economic Evaluation of Health and Care Interventions on the prevalence and economic burden on medication errors in the National Health Service in England. Prevalence and Economic Burden of Medication Errors in the NHS in England was published in February 2018.</p><p> </p><p>This study estimated a range of costs to the NHS depending on which costs are included in the analysis. The range is from a baseline of £98.5 million per annum. The highest cost scenario has estimated costs to the NHS of £1.6 billion.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/11/2018 11:42:40 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4131 label Biography information for Jim Shannon

1002536

	registered interest
	date	06/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the number of medication errors made each year in the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	188824
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>I refer the hon. Member to the answer I gave on 9 October 2018 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2018-09-12/174058/" target="_blank">174058</a>.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/11/2018 11:44:56 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4131 label Biography information for Jim Shannon

1002537

	registered interest
	date	06/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department has examined the (a) rate and (b) local effect on health of medication errors in each region of England and Wales.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	188825
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>NHS Digital currently collects data on select indicators for safer prescribing, with the first phase focused on admissions related to gastrointestinal bleeding and acute kidney injury. These indicators link hospital admission to prescription data, and identify the population at risk of harm at a national, regional, or clinical commissioning group level for each given indicator. Data may be used by local teams to alter prescribing practice to lower the risk associated with prescriptions where appropriate.</p><p> </p><p>Data are available publicly through the Medicine Safety Dashboard at the following link:</p><p> </p><p><a href="https://apps.nhsbsa.nhs.uk/MOD/MedicationSafety/atlas.html" target="_blank">https://apps.nhsbsa.nhs.uk/MOD/MedicationSafety/atlas.html</a></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/11/2018 11:46:40 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4131 label Biography information for Jim Shannon

1002591

	registered interest
	date	06/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to extend the expiration date of medicines to reduce waste; and if he will make a statement.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	188702
	answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>Any change to the expiry date of a medicine requires an independent review of the stability study by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicine Agency in consultation with the MHRA. The MHRA is the Government agency responsible for ensuring that medicines and medical devices work and are acceptably safe.</p><p> </p><p>Companies can and often do extend the shelf life of their medicines once the product is on the market and additional stability data become available. The MHRA is not able to insist on lengthy shelf lives considering the time needed to complete stability studies as to do so would create additional delays with bringing new medicines to the market. It is not possible however to extend the expiry date of all medicines unilaterally in the absence of supporting stability data.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 12/11/2018 15:39:28 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	252 label Biography information for Dr David Drew

1003833

	registered interest
	date	09/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the (a) supply and (b) availability of the drug Methotrexate after the UK leaves the EU.
	tabling member constituency	Great Grimsby
	tabling member printed	Melanie Onn
	uin	189738
	answer	answer is ministerial correction date of answer 15/11/2018 answer text <p>The United Kingdom’s position on medicines regulation remains clear. We are working to retain a close working partnership with the European Union to ensure that medicines remain available to UK patients in a safe and timely manner. We have been clear that this involves us making sure our regulators continue to work together, as they do with regulators internationally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/11/2018 12:46:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4464 label Biography information for Melanie Onn

1011510

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what advice he has issued to manufacturers of general sales list medicines on whether to stockpile medicines in preparation for the UK leaving the EU without a deal; whether he plans to update that advice before the end of 2018; and if he will make a statement.
	tabling member constituency	Darlington
	tabling member printed	Jenny Chapman
	uin	194157
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194158 194159 question first answered 26/11/2018 16:08:43 answering member 1585 label Biography information for Stephen Hammond
	tabling member	3972 label Biography information for Baroness Chapman of Darlington

1011511

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people presenting at NHS services because they are unable to purchase general sales list medicines for (a) themselves and (b) their children in the event that the UK leaves the EU without a deal; and if he will make a statement.
	tabling member constituency	Darlington
	tabling member printed	Jenny Chapman
	uin	194158
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194157 194159 question first answered 26/11/2018 16:08:44 answering member 1585 label Biography information for Stephen Hammond
	tabling member	3972 label Biography information for Baroness Chapman of Darlington